Patent · US Active

Method of treating neuronal injury by administering magnesium chloride and PEG

US8840933B2 · kind B2 · utility

2Cited by
6References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 3, 2006
Grant dateSep 23, 2014
Priority date—
Expiry dateJan 14, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K33/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides methods and kits for treatment of pain or inflammation. In one embodiment, the kit comprises a biomembrane sealing agent, such as PEG, and a bioactive agent, such as a magnesium compound. The biomembrane sealing agent and/or the bioactive agent an intravenous administration, an intramuscular administration, an intrathecal administration, a subcutaneous administration, an epidural administration, a parenteral administration, an intra-articular administration, a direct application onto or adjacent to a site of the pathological condition, and any combinations thereof. Alternatively, the biomembrane sealing agent and/or the bioactive agent may be delivered from a pump or an implant.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.